Cardiovascular Disease

PHILADELPHIA — In this video exclusive, Cynthia A. Stuenkel, MD, MSCP, talks about selecting therapies for menopausal symptoms for women with a history of cardiovascular disease.

Older adults with type 2 diabetes are less likely to have a cardiovascular event if they are initially prescribed an SGLT2 inhibitor or GLP-1 receptor agonist instead of a DPP-IV inhibitor, according to findings published in Diabetes Care.

Novel therapeutics have led to significant survival improvements for many cancers.

In a hearing on September 21, an FDA committee rejected an implantable device capable of delivering a GLP-1 receptor agonist for adults with type 2 diabetes.

Patients with psoriasis are at an increased risk for experiencing asymptomatic coronary microvascular dysfunction and should be actively evaluated for risk factors by dermatologists, according to a study.

The risk for death and hospitalizations due to cardiovascular disease in patients with obstructive sleep apnea decreased with use of CPAP, according to a presentation at the European Respiratory Society International Congress.

Added sugar, total sugar and fructose from some sources were all linked to a higher risk for coronary heart disease, according to the results of research published in the American Journal of Clinical Nutrition.

All-cause and cardiovascular mortality rates remained flat from 2006 to 2020 for people with type 1 diabetes who had a first-time myocardial infarction, despite mortality rates declining for type 2 diabetes, according to two presenters.

The rate of obesity-related cardiovascular deaths tripled from 1999 to 2020 — a rise that has taken the greatest toll on underrepresented groups, according to a study.